(Q35129031)

6 August 2017

1 reference

title

Fungal infections in the recipients of solid organ transplantation (English)

1 reference

6 August 2017

organ transplantation

1 reference

Nina Singh

1

1 reference

6 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12751263

3 January 2024

publication date

1 March 2003

1 reference

full work available at URL

6 August 2017

https://api.elsevier.com/content/article/PII:S0891552002000673?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(02)00067-3

https://api.elsevier.com/content/article/PII:S0891552002000673?httpAccept=text/plain

3 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(02)00067-3

Infectious Disease Clinics of North America

3 January 2024

published in

1 reference

6 August 2017

17

1 reference

6 August 2017

1

1 reference

6 August 2017

113-34, viii

1 reference

Risk factors for systemic fungal infections in liver transplant recipients

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Risk factors for invasive fungal infections complicating orthotopic liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Clinical spectrum of fungal infections after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Liver transplantation: current status and novel approaches to liver replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Primary liver transplantation without transfusion of red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Biliary reconstruction without T tubes or stents in liver transplantation: report of 502 consecutive cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Trends in invasive fungal infections in liver transplant recipients: correlation with evolution in transplantation practices

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Selection of Candida glabrata strains with reduced susceptibility to azoles in four liver transplant patients with invasive candidiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Invasive aspergillosis in transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

CNS aspergillosis in organ transplantation: a clinicopathological study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

INVASIVE ASPERGILLOSIS IN LIVER TRANSPLANT RECIPIENTS IN THE 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Human herpesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Fungal infections in lung and heart-lung transplant recipients. Report of 9 cases and review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Aspergillus airway colonization and invasive disease after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Infection in the transplanted and native lung after single lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Pulmonary aspergillosis in cystic fibrosis lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Hospitalizations for fungal infections after renal transplantation in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Characterization and impact of wound infection after pancreas transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Pneumonia After Heart Transplantation: A Multiinstitutional Study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Infections due to dematiaceous fungi in organ transplant recipients: case report and review

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Fusarium infection after solid-organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Invasive gastrointestinal zygomycosis in a liver transplant recipient: case report and review of zygomycosis in solid-organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Histoplasmosis in renal allograft recipients. Two large urban outbreaks

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Coccidioidomycosis in liver transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Blastomycosis in transplant recipients: report of a case and review

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Cryptococcal meningitis after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Aspergillus fumigatus conidia induce a Th1-type cytokine response

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Th1 and Th2 cytokines in mice with invasive aspergillosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Rejection treatment and cytomegalovirus infection as risk factors for Pneumocystis carinii pneumonia in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for management

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Disseminated histoplasmosis in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Disseminated coccidioidomycosis detected by percutaneous liver biopsy in a liver transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Aspergillus infection of the respiratory tract after lung transplantation: chest radiographic and CT findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Critical assessment of issues in the diagnosis of invasive aspergillosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Aspergillus antigenemia sandwich-enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Plasma (1-->3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Polymerase Chain Reaction Detection ofAspergillusDNA in Experimental Models of Invasive Aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Safety of aerosolized amphotericin B lipid complex in lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Prophylaxis of invasive mycoses in solid organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Estimating the true cost of amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Analysis of compassionate use itraconazole therapy for invasive aspergillosis by the NIAID Mycoses Study Group criteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Practice guidelines for the management of patients with histoplasmosis. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900067-3

7 January 2021

Risk factors for deep candida infections in liver transplant recipients

7

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(02)00067-3

Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome

3 January 2024

32

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(02)00067-3

Infectious complications after small bowel transplantation in adults: an update

3 January 2024

35

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(02)00067-3

Disseminated histoplasmosis in renal allograft recipients

3 January 2024

40

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(02)00067-3

Coccidioidomycosis and heart transplantation

3 January 2024

42

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(02)00067-3

Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis

3 January 2024

79

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(02)00067-3

Itraconazole for the treatment of pulmonary aspergillosis in heart transplant recipients

3 January 2024

83

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(02)00067-3

3 January 2024

Identifiers

1 reference

6 August 2017

1 reference